Samuel Z. Goldhaber, MD, offers insight into how healthcare providers can protect medically ill patients from developing VTE and stroke.
From the 19th Annual Antithrombotic Therapy Symposium, Wayne State University
Related Articles
July 17, 2019
The Good, The Bad, and The Ugly of Atrial Fibrillation
Dr. Steven Deitelzweig discusses opportunities for improving anticoagulant management, an evidence-based risk assessment, how pivotal trials and guidelines are used…
June 19, 2019
Clot Chronicles: Treating VTE in Cancer
Hello, I’m Dr. Sam Goldhaber, President of NATF, and I’m talking with you today on Clot Chronicles about new strategies…
June 19, 2019
Update on Anticoagulant Reversal Agents
Dr. Margaret Fang presents an update on anticoagulant reversal agents.